 |
|
 |
Robust Methods for several ther- |
|
| |
-apeutic areas. |
|
 |
Controlled substance methods |
|
| |
(CII-CV). |
|
 |
Preclinical and clinical sample an- |
|
| |
-alysis. |
|
 |
BA/BE studies & PK/TK data ana- |
|
| |
-lysis. |
|
 |
State of the art equipment. |
|
 |
Reports in eCTD format. |
|
 |
Access to clinics in USA, Canada& |
|
| |
India. |
|
 |
Complete project management. |
|
 |
Electronic submission services. |
|
 |
Strict adherence to GLP. |
|
 |
Strict security and confidentiality. |
|
| |
 |
|
 |
|
 |
Method Development |
|
 |
Method Validation |
|
 |
Pre clinical & clinical sample ana- |
|
| |
-lysis. |
|
 |
Report preparation for bioanalyt- |
|
| |
-ical studies reporting. |
|
 |
Pharmacokinetic & Toxicokinetic |
|
| |
Statistics |
|